News - Page 11

If you have a stroke, the protein FSAP may help to reduce the extent of paralyses and problems with speech.

The European Innovation Council Pathfinder Challenges program funds the international research consortium ¡°Supervised Morphogenesis in Gastruloids¡± - SUMO

In the Middle Ages, people of high status were both taller and had higher bone density than those from modest backgrounds. This difference was most marked amongst women, shows a new study based on the Schreiner Collection.

The health and level of functioning of older adults with cancer varies. A comprehensive assessment of the patient's needs in advance of cancer treatment can improve treatment and lead to more treatment choices for the patients.

Almost half of all patients with heart failure have an "unknown" type. Researchers at UiO have studied whether biomarkers can provide better opportunities for diagnosis.

You are sitting in a meeting at work and your mind starts to wander to another place. Suddenly, you realise that the person leading the meeting has asked you a question that you have not heard. Why does this happen?

India produces 20 percent of all generic medicines worldwide, but depends on ingredients from China to make the medicines.

New study shows that colonoscopy-screening reduces the risk of getting colorectal cancer by 18 percent. The reduction is less than experts previously assumed.

Study contributes to new knowledge about what prevents and promotes family involvement in treatment of patients with severe mental disorders.

Why does it become harder to concentrate when you have Alzheimer¡¯s disease? The explanation is perhaps that the signals transmitted from glial cells to nerve cells are disrupted.

Some patients get a serious infection in the eye after eye surgery. The risk of becoming blind is high without prompt treatment. A new approach to diagnostics and treatment can help save patients¡¯ vision.

The patients are recommended controls every three years. 

Hanne Flinstad Harbo won the election for the position of dean at the Faculty of Medicine with 53% of the votes. She will be the faculty's first female dean.

The new Jebsen centre opened on 1 September and will have a duration of five years. The aim of the centre's research is to improve the prevention and treatment of heart disease. The Centre is led by Professor Torbj?rn Omland.

Five research environments from MED reached this year's FRIPRO award. One research environment from IMB and four from Klinmed received support.

Higher prison security level is linked to greater risk of dying after release. Preventive measures can reduce the mortality rate.  

By using drugs currently used to treat other diseases, scientists hope they will help children with leukemia suffer fewer long-term aftereffects from their treatment.

It appears unnecessary to perform surgery on patients who have the mild variant of the disease PHPT, where the level of calcium in the blood is only slightly higher than usual.

Nursing science at the Department of Health and Society, University of Oslo is ranked number 47 in this year's ShanghaiRanking - 2022 Global Ranking of Academic Subjects.

Many patients stop taking medication for high cholesterol because they are afraid it may have negative side effects. But the observed association between risk of dementia and high cholesterol, may be caused by your lifestyle.

The gene helps to repair brain damage caused by a lack of oxygen during birth, Norwegian researchers found.

How many cups of coffee you drink when you are pregnant does not seem to negatively affect the weight of the baby, whether it is born prematurely, or your risk of miscarriage or stillbirth.

Letting your baby taste foods that contain peanuts, eggs, milk and wheat from the age of three months can reduce the risk of allergies in children.

The environmental pollutants we consume are probably the reason why some people develop type 1 diabetes. Even low concentrations of such pollutants can result in cells producing less insulin, reveals a new study from the University of Oslo (UiO).

Dr. Yuichi Mori at the Clinical Effectiveness Research Group will lead a large new research project that aims to find solutions for clinical validation of artificial intelligence. The goal is to improve the diagnosis and therapy of colorectal cancer and polyps.